Windtree Therapeutics to be delisted from Nasdaq due to failure to meet minimum closing price maintenance criteria
-
最新报道：According to Bijie.com, Windtree Therapeutics, the company behind the "BNB microstrategy," received notice from Nasdaq on August 19, 2025, stating that its common stock would be delisted from the Nasdaq Capital Market and transferred to the OTC market on August 21 due to failure to meet the minimum closing price maintenance standard (Rule 5550(a)(2)). Previously, the company had announced plans to raise up to $520 million through equity financing, 99% of which would be used to purchase BNB.
下一篇
Argot Collective launches Ethereum strategic reserve, currently holding 2,474 ETH
- According to a post on the X platform by Strategic ETH Reserve, Argot Collective has launc...
24小时热点
热点专题
413361